Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones
- PMID: 31289413
- PMCID: PMC6615762
- DOI: 10.1016/j.tet.2018.10.078
Application of vinylogous carbamates and vinylogous aminonitriles to the regiospecific synthesis of uniquely functionalized pyrroles and quinolones
Abstract
Pyrroles and quinolones represent core structures, which are routinely found in both natural and synthetic bioactive substances. Consequently, the development of efficient and regiospecific methods for the preparation of such heterocycles with unique functionality is of some importance. We describe herein the regiospecific synthesis of 1,2,3,4-tetrasubstituted pyrroles containing polar substituents and such products are prepared from vinylogous carbamates and vinylogous aminonitriles. We also describe the regiospecific synthesis of 3-aryl containing 1,3,6trisubstituted quinolones from vinylogous carbamates. The use of an amine exchange reaction to prepare precursors for the pyrrole and quinolone forming cyclizations represents a key factor in the strategy.
Keywords: Pyrrole; Quinolone; Vinylogous Aminonitrile; Vinylogous Carbamate.
Figures










References
-
- For some recent examples see: (a) Xu X; Ratnikov M; Zavalij P; Doyle M Org. Lett 2011, 13, 6122; - PMC - PubMed
- (b) Li X; Chen M; Xie X; Sun N; Li S; Liu Y; Org.Lett 2015, 17, 2984; - PubMed
- (c) Kim C; Park S; Eom D; Seo B; Lee P; Org. Lett 2014, 16, 190; - PubMed
- (d) Zheng J; Huang L; Huang C; Wu W; Jiang H; J. Org. Chem 2015, 80, 1235; - PubMed
- (e) Kim D; Seo Y; Jun C ; Org. Lett 2015, 17, 3842. - PubMed
- (f) Zhang X; Xu X; Chen G; Yi W; Org. Lett 2016, 18, 4864. - PubMed
- (g) Bailly C; Curr. Med. Chem.– Anti-Cancer Agents, 2004, 363. - PubMed
- (h) Gupton J, “Pyrrole Natural Products with Antitumor Properties”, in “Heterocyclic Antitumor Antibiotics: Topics in Heterocyclic Chemistry, Vol.2”, Ed. Lee M pp 53–92, Springer-Verlag, Berlin/Heidelberg, 2006.
-
- For some recent examples see: (a)Wu J; Zhou Y; Wu T; Zhou Y; Chiang CH; Lei A; Org. Lett 2017, 19, 6432; - PubMed
- (b) Xu X; Zhang X; Org. Lett 2017, 19, 4984; - PubMed
- (c) Pinto J; Silva V; Silva AMG; Santos L; Silva AMS; J. Org. Chem 2015, 80, 6649; - PubMed
- (d) Zhao T; Xu B Org. Lett 2010, 12, 212; - PubMed
- (e) Nilsen A; Miley G; Forquer I; Mather M; Katneni K; Li Y; Pou S; Pershing A; Stickles A; Ryan E; Kelly J; Doggett J; White K; Hinrichs D; Winter R; Charman S; Zakharov L; Bathurst I; Burrows J; Vaidya A; Riscoe MJ Med. Chem 2014, 57, 3818. - PMC - PubMed
- (f) Xu X; Sun R; Zhang S; Zhang X; Yi W Org. Lett 2018, 20, 1893; - PubMed
- (g) Manetsch R; Cross R J.Org.Chem 2010, 75, 8654. - PubMed
-
- Dialer C; Imbri D; Hansen S; Opatz T; J. Org. Chem 2015, 80 ,11605. - PubMed
-
- Lin H; Dai C; Jamison T; Jensen K; Angew. Chem. Int. Ed 2017, 56, 8870. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources